汕头那治疗白癜风效果好揭阳哪家治白癜风治得好,白癜风揭阳看的最好的,普宁19岁女孩患上白癜风,潮州能治白癜风哪最好,梅州治疗白癜风可以报销吗,揭阳哪个治疗白癜风专业,潮州白癜风在哪治疗好

KANSAS CITY, Mo. — Priority Care Pediatrics in Kansas City requires its patients to follow the CDC immunization schedule.With the recent measles outbreak in the Kansas City area, the office made a post on Facebook to educate parents and reaction was swift.Dr. Raymond Cattaneo said that post, "Turned into something much bigger than that when some anti-vaccine people got a hold of that and bombarded our post. Reading comment after comment after comment you just kind of get worn down because you know you're fighting the good fight. You're on the right side of science but you worry that what they're saying, people will actually believe."Kristen Kleffner is a mom of four who got a letter from her son's school."We've done everything we can on our end but that doesn't necessarily mean they're still safe," Kleffner said. "You hear about measles outbreaks but you don't realize it's going to hit so close to home."Cattaneo told Scripps station KSHB in Kansas City, "Measles is one of the most contagious illnesses out there. It's a scary thing, especially when we know we have an immunization that can prevent this from happening."He added that it doesn't take many people for an outbreak to turn into an epidemic."The science is clear, this is about saving kids lives," Cattaneo said. 1301

LA JOLLA, Calif. (KGTV) - A researcher at UC San Diego just got a million grant to further his work into nanosponge therapy.Liangfang Zhang, a professor of nanoengineering and bioengineering, has been working on creating macrophage cellular nanosponges, tiny particles covered in white blood cell membranes, to treat sepsis and other diseases."They can be used to bind to the virus and neutralize the virus," Zhang says. "So now the virus would lose the ability to infect the host cells."The nanosponges act as decoys, tricking a disease or virus into binding with them instead of with human cells. While the initial aim is to treat sepsis, Zhang says it has applications to other deadly diseases, including COVID-19."The formulation that we're developing for treatment of Sepsis is the same formulation that you will use with COVID-19," he says.The grant comes from CARB-X, a Boston-based medical philanthropy that specializes in funding research into antibacterial treatments. Zhang says the money will be used for his company, Cellics Therapeutics, to further advance the research into clinical trials, FDA approval, and production of the nanosponge therapy.Steve Chen, president and chief medical officer of Cellics Therapeutics, says he's hopeful they can advance the nanosponges into human trials within two years."We're essentially looking at how this platform can treat not just infectious disease or future pandemics, but you could actually have a lot of applications in any type of autoimmune diseases or any type of inflammatory diseases," says Chen.In an early study published this year, Zhang's research showed the nanosponges were around 90% effective at blocking infections from taking hold.RELATED: UC San Diego researchers testing nanosponges to fight COVID-19Chen says the research and trial period may take too long for the nanosponges to be used during the current coronavirus pandemic. But he's hopeful it will help make the next outbreak less severe."My sincere desire is that we are not going to need this for COVID-19. But I think this does position us very well for any potential future kind of viral outbreak," says Chen.Cellics is also working on a Red Blood Cell version of their nanosponges, which may be ready for human trials within a year. 2283

KANSAS CITY, Mo. - As a former traveling nurse, Samantha Hessing said several companies reach out to her almost every day with offers to send her to hospitals that are in dire need while battling COVID-19."There’s a nursing shortage, that's never gone away," Hessing said, "and all that's happening now is these big hospitals are providing enough cash offers to draw a vast majority of them."Though its grueling work, the pay can be upwards of ,000 per week."I've seen numbers anywhere from ,600 a week, up to almost ,000 a week," Hessing said. "That is with mandatory overtime. So some of those contracts, it is written in that you'll work 48 or 60 hours a week."But Hessing also said the higher the pay, the shorter contract – about 6 to 8 weeks instead of the usual 13 weeks.Traveling nurses have made up about 6% of Truman Medical Centers' nursing staff since COVID-19 broke out."The ability to supplement that with agency or traveling staff is certainly helpful. But realizing that's an area that is very much in demand," Charlie Shields, president and CEO of Truman Medical Centers/University Health, said.Some nurses found the concept of traveling appealing when elective surgeries went away at the onset of the pandemic."So many things had shut down that there wasn't actually an opportunity for some of the nurses to work or get hours," Hessing said. "And so they did. They left and took travel assignments."Hessing said Kansas City, Missouri, is a bigger draw for traveling nurses because it's a metropolitan area, but worries that not all hospital systems in the metro are as lucky."It's causing a pretty big deficit for smaller hospitals or rural hospitals that don't have the resources to be able to offer that," Hessing said.This story was first reported by Andres Gutierrez at KSHB in Kansas City, Missouri. 1836

Kimberly Guilfoyle has tested positive for COVID-19 and was unable to attend Fourth of July festivities at Mount Rushmore alongside the presidential family. New York Times and ABC News both reported Guilfoyle’s positive test.Guilfoyle is the girlfriend of Donald Trump Jr., and is also a member of President Donald Trump’s re-election campaign.Guilfoyle reportedly flew to South Dakota with Donald Trump Jr., but flew separately from the president.Guilfoyle was tested for the virus, along with many others who could come in close contact with the president.Trump Jr. reportedly tested negative for the virus. 617

Jack Hanna, a local legend who brought his passion for wildlife and people in front of televisions across the world, has announced his retirement after 42 years, the Columbus Zoo said Thursday.Jungle Jack Hanna, as he is affectionately called by his fans, will retire as the director on Dec. 31, 2020.“Out of respect for the many people whose lives the Hannas have touched, this news is being shared now to give the community ample time throughout the rest of the year to celebrate and thank Jack and Suzi,” the zoo said in a statement.Since the beginning of his career, he has transformed the role zoos play in their communities and globally. Hanna first arrived in Ohio in 1965 to attend Muskingum University. Always the animal lover, he even brought his pet donkey with him to live in the fraternity house. While at Muskingum, Jack met his wife, Suzi, and they married in 1968. 888